(c) 2024 PillSync.com

pregabalin 50 mg

1 INDICATIONS AND USAGE Pregabalin is indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pregabalin is indicated for: neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) Postherpetic neuralgia (PHN) ( 1 ) Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) fibromyalgia ( 1 ) neuropathic pain associated with spinal cord injury ( 1 )

Ascend Laboratories, LLC


1 year ago CAPSULE WHITE A008 PREG 50 pregabalin 50 mg

CAPSULE WHITE A008 PREG 50

16 HOW SUPPLIED/STORAGE AND HANDLING 25 mg capsules: white to off white powder filled in size"4" hard gelatin capsules, white opaque cap imprinted with 'A007' with black ink and white opaque body imprinted with "PREG 25"with black ink, available in: Bottles of 30: NDC-67877-462-30 Bottles of 90: NDC-67877-462-90 Bottles of 500: NDC-67877-462-05 Unit-Dose Blister Packages of 100 (10×10): NDC-67877-462-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-462-33 50 mg capsules: white to off white powder filled in size"3" hard gelatin capsules, white opaque cap imprinted with 'A008' with black ink and white opaque body imprinted with "PREG 50"with black ink, available in: Bottles of 30: NDC-67877-463-30 Bottles of 90: NDC-67877-463-90 Bottles of 500: NDC-67877-463-05 Unit-Dose Blister Packages of 100 (10×10): NDC-67877-463-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-463-33 75 mg capsules: white / orange hard gelatin capsules, imprinted with black ink ‘A009’ on the cap and “PREG 75” on the body; available in: Bottles of 30: NDC-67877-464-30 Bottles of 90: NDC-67877-464-90 Bottles of 500: NDC-67877-464-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-464-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-464-33 100 mg capsules: orange hard gelatin capsules, imprinted with black ink ‘A010’ on the cap and “PREG 100” on the body; available in: Bottles of 30: NDC-67877-465-30 Bottles of 90: NDC-67877-465-90 Bottles of 500: NDC-67877-465-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-465-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-465-33 150 mg capsules: white hard gelatin capsules, imprinted with black ink ‘A011’ on the cap and “PREG 150” on the body; available in: Bottles of 30: NDC-67877-466-30 Bottles of 90: NDC-67877-466-90 Bottles of 500: NDC-67877-466-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-466-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-466-33 200 mg capsules: Light orange hard gelatin capsules, imprinted with black ink ‘A012’ on the cap and “PREG 200” on the body; available in: Bottles of 30: NDC-67877-467-30 Bottles of 90: NDC-67877-467-90 Bottles of 500: NDC-67877-467-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-467-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-467-33 225 mg capsules : white / light orange hard gelatin capsules, imprinted with black ink ‘A013’ and “PREG 225” on the body; available in: Bottles of 30: NDC-67877-468-30 Bottles of 90: NDC-67877-468-90 Bottles of 500: NDC-67877-468-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-468-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-468-33 300 mg capsules: white / light orange hard gelatin capsules, imprinted with black ink ‘A014’ and “PREG 300” on the body; available in: Bottles of 30: NDC-67877-469-30 Bottles of 90: NDC-67877-469-90 Bottles of 500: NDC-67877-469-05 Unit-Dose Blister Packages of 100(10×10): NDC-67877-469-38 Unit-Dose Blister Pack of 10 (1x10): NDC-67877-469-33 Storage and Handling Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature].


More pills like CAPSULE A008 PREG 50












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site